| Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities Y Wen, J Lambrecht, C Ju, F Tacke Cellular & molecular immunology 18 (1), 45-56, 2021 | 351 | 2021 |
| Integrative miRNA and gene expression profiling analysis of human quiescent hepatic stellate cells M Coll, AE Taghdouini, L Perea, I Mannaerts, M Vila-Casadesús, D Blaya, ... Scientific Reports 5 (1), 11549, 2015 | 98 | 2015 |
| Current and emerging pharmacotherapeutic interventions for the treatment of liver fibrosis J Lambrecht, LA van Grunsven, F Tacke Expert opinion on pharmacotherapy 21 (13), 1637-1649, 2020 | 67 | 2020 |
| Circulating ECV-associated miRNAs as potential clinical biomarkers in early stage HBV and HCV induced liver fibrosis J Lambrecht, P Jan Poortmans, S Verhulst, H Reynaert, I Mannaerts, ... Frontiers in pharmacology 8, 56, 2017 | 57 | 2017 |
| Prospects in non-invasive assessment of liver fibrosis: Liquid biopsy as the future gold standard? J Lambrecht, S Verhulst, I Mannaerts, H Reynaert, LA van Grunsven Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1864 (4 …, 2018 | 54 | 2018 |
| The role of miRNAs in stress-responsive hepatic stellate cells during liver fibrosis J Lambrecht, I Mannaerts, LA van Grunsven Frontiers in physiology 6, 150919, 2015 | 47 | 2015 |
| A PDGFRβ-based score predicts significant liver fibrosis in patients with chronic alcohol abuse, NAFLD and viral liver disease J Lambrecht, S Verhulst, I Mannaerts, JP Sowa, J Best, A Canbay, ... EBioMedicine 43, 501-512, 2019 | 32 | 2019 |
| Lessons from immune checkpoint inhibitor trials in hepatocellular carcinoma R Mohr, F Jost-Brinkmann, B Özdirik, J Lambrecht, L Hammerich, ... Frontiers in Immunology 12, 652172, 2021 | 28 | 2021 |
| The miRFIB-score: a serological miRNA-based scoring algorithm for the diagnosis of significant liver fibrosis J Lambrecht, S Verhulst, H Reynaert, LA van Grunsven Cells 8 (9), 1003, 2019 | 26 | 2019 |
| Controversies and opportunities in the use of inflammatory markers for diagnosis or risk prediction in fatty liver disease J Lambrecht, F Tacke Frontiers in Immunology 11, 634409, 2021 | 25 | 2021 |
| From liver cirrhosis to cancer: the role of micro-RNAs in hepatocarcinogenesis R Mohr, B Özdirik, J Lambrecht, M Demir, J Eschrich, L Geisler, T Hellberg, ... International journal of molecular sciences 22 (3), 1492, 2021 | 22 | 2021 |
| The APAC score: a novel and highly performant serological tool for early diagnosis of hepatocellular carcinoma in patients with liver cirrhosis J Lambrecht, M Porsch-Özçürümez, J Best, F Jost-Brinkmann, ... Journal of Clinical Medicine 10 (15), 3392, 2021 | 17 | 2021 |
| Studying metabolism with multi-organ chips: new tools for disease modelling, pharmacokinetics and pharmacodynamics T Shroff, K Aina, C Maass, M Cipriano, J Lambrecht, F Tacke, A Mosig, ... Open Biology 12 (3), 210333, 2022 | 15 | 2022 |
| The role of miRNA in the pathophysiology of neuroendocrine tumors L Geisler, R Mohr, J Lambrecht, J Knorr, H Jann, SH Loosen, B Özdirik, ... International Journal of Molecular Sciences 22 (16), 8569, 2021 | 7 | 2021 |
| Serum levels of miR-223 but not miR-21 are decreased in patients with neuroendocrine tumors T Hellberg, R Mohr, L Geisler, J Knorr, A Wree, M Demir, F Benz, ... Plos one 15 (12), e0244504, 2020 | 4 | 2020 |
| Acetyl-CoA Carboxylase Inhibition as a Therapeutic Tool in the Battle Against NASH: Hitting More Than Just One Mechanism? J Lambrecht, F Tacke Cellular and Molecular Gastroenterology and Hepatology 10 (4), 859-861, 2020 | 4 | 2020 |
| Serum CXCL5 detects early hepatocellular carcinoma and indicates tumor progression A Laschtowitz, J Lambrecht, T Puengel, F Tacke, R Mohr International Journal of Molecular Sciences 24 (6), 5295, 2023 | 2 | 2023 |
| Inflammatory Cytokines Associated with Diagnosis, Tumor Grade and Prognosis in Patients with Neuroendocrine Tumors L Geisler, T Hellberg, J Lambrecht, H Jann, J Knorr, J Eschrich, ... Journal of Clinical Medicine 11 (20), 6191, 2022 | 1 | 2022 |
| The discovery of novel biomarkers for early stage liver fibrosis J Lambrecht | | 2020 |
| A SEROLOGICAL miRNA-BASED ALGORITHM (MIRFIB) FOR THE IDENTIFICATION OF SIGNIFICANT LIVER FIBROSIS IN PATIENTS WITH CHRONIC ALCOHOL ABUSE, NAFLD, AND VIRAL LIVER DISEASE J Lambrecht, S Verhulst, H Reynaert, LA Van Grunsven Hepatology 70, 1237A-1238A, 2019 | | 2019 |
